Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit

A C Downie1, P G Frost, P Fielden

  • 1Central Middlesex Hospital NHS Trust, London, UK.

Lancet (London, England)
|February 20, 1993
PubMed

Insights

Bedside creatine kinase testing by nurses enabled earlier diagnosis of myocardial infarction in 59% of confirmed cases. This improved access to timely thrombolytic therapy for acute myocardial infarction patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Diagnostics

Background:

  • Thrombolysis is a critical treatment for acute myocardial infarction (AMI) within 12 hours of symptom onset.
  • Early diagnosis is crucial, but some AMI patients do not meet diagnostic criteria upon admission, delaying or preventing thrombolysis.
  • Current diagnostic methods may not be rapid enough for immediate treatment decisions in all suspected cases.

Purpose of the Study:

  • To evaluate the effectiveness of bedside creatine kinase (CK) assays performed by nurses for early diagnosis of myocardial infarction.
  • To determine if this method can increase the number of patients receiving timely thrombolytic therapy.

Main Methods:

  • A study of 117 patients admitted to a coronary care unit with suspected myocardial infarction.
  • Nurses measured creatine kinase levels using capillary blood samples and a dry chemistry system at the bedside.
  • Creatine kinase levels were monitored over time to assess for elevations indicative of infarction.

Main Results:

  • Myocardial infarction was confirmed in 29 out of 117 patients.
  • Of the confirmed cases, 17 patients (59%) were correctly diagnosed using the bedside CK assay.
  • These 17 patients received thrombolytic therapy within the critical 12-hour window.

Conclusions:

  • Bedside CK assays performed by nurses can facilitate earlier diagnosis of acute myocardial infarction.
  • This diagnostic approach allows more patients to benefit from time-sensitive thrombolytic therapy.
  • Implementing point-of-care testing can improve patient outcomes in acute coronary syndromes.

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...